
A major U.S. hospital system had a strong rebound in most cancer screening tests after a steep drop-off in the early months of the COVID-19 pandemic, a new study shows. The findings are based on an analysis of data from the Boston-based Mass General Brigham system. Depending on the type of test, between March and… read on > read on >